The role of lipocalin-2 in liver regeneration

Liver International

Volumn 35, Issue 4, 2015, Pages 1195-1202

  Kienzl Wagner, Katrin ^a   Moschen, Alexander R ^a   Geiger, Sabine ^a   Bichler, Alexandra ^a   Aigner, Felix ^a   Brandacher, Gerald ^b   Pratschke, Johann ^a   Tilg, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Hepatic proliferation; LCN2; Lipocalin 2; Liver regeneration; Partial hepatectomy

Indexed keywords

INTERLEUKIN 1BETA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; LCN2 PROTEIN, HUMAN; LCN2 PROTEIN, MOUSE; LIPOCALIN; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLS BY BODY ANATOMY; CONTROLLED STUDY; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LIVER REGENERATION; LIVER RESECTION; LIVER SURGERY; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; SHAM PROCEDURE; WILD TYPE; ADULT; AGED; ANIMAL; BLOOD; DEFICIENCY; FEMALE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; SIGNAL TRANSDUCTION; SURGERY; TIME; UPREGULATION;

ACUTE-PHASE PROTEINS; ADULT; AGED; ANIMALS; BIOMARKERS; FEMALE; HEPATECTOMY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-6; LIPOCALINS; LIVER; LIVER REGENERATION; MALE; MICE, KNOCKOUT; MIDDLE AGED; ONCOGENE PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 84924569171     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12634     Document Type: Article

References (42)

1. Bohm F, Kohler UA, Speicher T, Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2010; 2: 294-305.
2. Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008; 322: 1490-4.
3. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120: 117-30.
4. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43(2 Suppl. 1): S45-53.
5. Clavien PA, Petrowsky H, Deoliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-59.
6. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996; 318(Pt 1): 1-14.
7. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004; 432: 917-21.
8. Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem 1995; 270: 22565-70.
9. Nielsen BS, Borregaard N, Bundgaard JR, et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996; 38: 414-20.
10. Aigner F, Maier HT, Schwelberger HG, et al. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007; 7: 779-88.
11. Jiang W, Constante M, Santos MM. Anemia upregulates lipocalin 2 in the liver and serum. Blood Cells Mol Dis 2008; 41: 169-74.
12. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J 2005; 19: 1881-3.
13. Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005; 123: 1293-305.
14. Paragas N, Qiu A, Zhang Q, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011; 17: 216-22.
15. Nickolas TL, O'rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810-9.
16. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, Group N M-a I. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 54: 1012-24.
17. Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007; 53: 34-41.
18. Ryon J, Bendickson L, Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 2002; 367(Pt 1): 271-7.
19. Yang J, Moses MA. Lipocalin 2: a multifaceted modulator of human cancer. Cell Cycle 2009; 8: 2347-52.
20. Playford RJ, Belo A, Poulsom R, et al. Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 2006; 131: 809-17.
21. Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007; 18: 407-13.
22. Viau A, El Karoui K, Laouari D, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010; 120: 4065-76.
23. Vinuesa E, Sola A, Jung M, Alfaro V, Hotter G. Lipocalin-2-induced renal regeneration depends on cytokines. Am J Physiol Renal Physiol 2008; 295: F1554-62.
24. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073-82.
25. Lai HS, Wu YM, Lai SL, Lin WH. Lipocalin-2 gene expression during liver regeneration after partial hepatectomy in rats. Int J Surg 2013; 11: 314-8.
26. Borkham-Kamphorst E, Drews F, Weiskirchen R. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappaB activation. Liver Int 2011; 31: 656-65.
27. Borkham-Kamphorst E, Van De Leur E, Zimmermann HW, et al. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. Biochim Biophys Acta 2013; 1832: 660-73.
28. Labbus K, Henning M, Borkham-Kamphorst E, et al. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions. J Proteomics 2013; 78: 188-96.
29. Melino M, Gadd VL, Walker GV, et al. Macrophage secretory products induce an inflammatory phenotype in hepatocytes. World J Gastroenterol 2012; 18: 1732-44.
30. Patil MA, Chua MS, Pan KH, et al. An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. Oncogene 2005; 24: 3737-47.
31. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008; 3: 1167-70.
32. Greene AK, Puder M. Partial hepatectomy in the mouse: technique and perioperative management. J Invest Surg 2003; 16: 99-102.
33. Moschen AR, Gerner R, Schroll A, et al. A key role for Pre-B cell colony-enhancing factor in experimental hepatitis. Hepatology 2011; 54: 675-86.
34. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-5.
35. Farrell GC. Probing Prometheus: fat fueling the fire? Hepatology 2004; 40: 1252-5.
36. Rudnick DA. Trimming the fat from liver regeneration. Hepatology 2005; 42: 1001-3.
37. Newberry EP, Kennedy SM, Xie Y, et al. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 2008; 48: 1097-105.
38. Brasaemle DL. Cell biology. A metabolic push to proliferate. Science 2006; 313: 1581-2.
39. Milner KL, Van Der Poorten D, Xu A, et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1926-34.
40. Cowland JB, Muta T, Borregaard N. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol 2006; 176: 5559-66.
41. Cowland JB, Sorensen OE, Sehested M, Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003; 171: 6630-9.
42. Boulton R, Woodman A, Calnan D, et al. Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology 1997; 26: 49-58.